APA (7th ed.) Citation

OKIYAMA, N., & TANAKA, R. (2017). Varied immuno-related adverse events induced by immune-check point inhibitors — Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6. Nihon Rinshō Menʾeki Gakkai kaishi, 40(2), 95-101. https://doi.org/10.2177/jsci.40.95

Chicago Style (17th ed.) Citation

OKIYAMA, Naoko, and Ryota TANAKA. "Varied Immuno-related Adverse Events Induced by Immune-check Point Inhibitors — Nivolumab-associated Psoriasiform Dermatitis Related with Increased Serum Level of Interleukin-6." Nihon Rinshō Menʾeki Gakkai Kaishi 40, no. 2 (2017): 95-101. https://doi.org/10.2177/jsci.40.95.

MLA (9th ed.) Citation

OKIYAMA, Naoko, and Ryota TANAKA. "Varied Immuno-related Adverse Events Induced by Immune-check Point Inhibitors — Nivolumab-associated Psoriasiform Dermatitis Related with Increased Serum Level of Interleukin-6." Nihon Rinshō Menʾeki Gakkai Kaishi, vol. 40, no. 2, 2017, pp. 95-101, https://doi.org/10.2177/jsci.40.95.